Beijing Airdoc Technology Co., Ltd. Stock

Equities

2251

CNE100004QQ9

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. 04:08:05 2024-05-31 am EDT 5-day change 1st Jan Change
15 HKD -0.13% Intraday chart for Beijing Airdoc Technology Co., Ltd. -.--% +23.97%

Financials

Sales 2024 * 340M 46.89M 367M Sales 2025 * 541M 74.71M 584M Capitalization 1.42B 197M 1.54B
Net income 2024 * -30M -4.14M -32.39M Net income 2025 * 25M 3.45M 26.99M EV / Sales 2024 * 1.4 x
Net cash position 2024 * 949M 131M 1.02B Net cash position 2025 * 949M 131M 1.02B EV / Sales 2025 * 0.88 x
P/E ratio 2024 *
-51.4 x
P/E ratio 2025 *
55.6 x
Employees 345
Yield 2024 *
-
Yield 2025 *
-
Free-Float 22.76%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.13%
Current month-7.52%
1 month-7.52%
3 months+8.07%
6 months+25.00%
Current year+23.97%
More quotes
1 week
14.50
Extreme 14.5
15.46
1 month
14.28
Extreme 14.28
17.10
Current year
10.02
Extreme 10.02
18.38
1 year
7.88
Extreme 7.88
18.38
3 years
7.88
Extreme 7.88
74.95
5 years
7.88
Extreme 7.88
74.95
10 years
7.88
Extreme 7.88
74.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 41 15-09-08
Director of Finance/CFO 39 20-12-24
Corporate Secretary - 22-01-18
Members of the board TitleAgeSince
Chief Executive Officer 41 15-09-08
Director/Board Member 66 21-04-29
Director/Board Member 49 22-05-18
More insiders
Date Price Change Volume
24-05-31 15 -0.13% 149,600
24-05-30 15.02 +0.67% 134,000
24-05-29 14.92 -2.23% 105,000
24-05-28 15.26 +1.73% 222,700
24-05-27 15 -.--% 96,600

Delayed Quote Hong Kong S.E., May 31, 2024 at 04:08 am EDT

More quotes
Beijing Airdoc Technology Co Ltd is a China-based company that provides AI-empowered retina-based early detection, diagnosis and health risk assessment solutions. The Company's main product is Airdoc-AIFUNDUS 1.0. The Company's product can be used in the diagnosis of glaucoma, cataract, ICVD and ASCVD, diabetic retinopathy of pregnancy, hypertensive retinopathy of pregnancy and other diseases. In addition, the Company has developed a deep pipeline of other Software-as-a-medical devices (SaMDs) and health risk assessment solutions to address various healthcare needs for the whole population, including hospitals, community clinics, health checkup centers, insurance companies, optometry centers and pharmacies.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
13.89 CNY
Average target price
18.69 CNY
Spread / Average Target
+34.56%
Consensus

Annual profits - Rate of surprise